Cargando…

Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS

Patient: Male, 64-year-old Final Diagnosis: Hemophilus influenzae and parainfluenza virus pneumonia in a patient with AIDS Symptoms: Shortness of breath Medication:— Clinical Procedure: Bronchoalveolar lavage Specialty: Infectious Diseases OBJECTIVE: Rare disease BACKGROUND: Parainfluenza viruses (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarakanti, Sandhya, Bishburg, Eliahu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377600/
https://www.ncbi.nlm.nih.gov/pubmed/32651354
http://dx.doi.org/10.12659/AJCR.923132
_version_ 1783562245233442816
author Nagarakanti, Sandhya
Bishburg, Eliahu
author_facet Nagarakanti, Sandhya
Bishburg, Eliahu
author_sort Nagarakanti, Sandhya
collection PubMed
description Patient: Male, 64-year-old Final Diagnosis: Hemophilus influenzae and parainfluenza virus pneumonia in a patient with AIDS Symptoms: Shortness of breath Medication:— Clinical Procedure: Bronchoalveolar lavage Specialty: Infectious Diseases OBJECTIVE: Rare disease BACKGROUND: Parainfluenza viruses (PIV) are known to cause mild respiratory tract infections in immunocompetent patients but can cause severe infections in immune-compromised patients such as transplant recipients and children with HIV. PIV infection in HIV-infected adults has rarely been reported. We report a case of PIV pneumonia in an adult with AIDS who was successfully treated with oral ribavirin. CASE REPORT: A 64-year-old man with history of acquired immune deficiency syndrome (AIDS) was admitted to the hospital with shortness of breath that began 3 days before. He was in respiratory distress and required mechanical ventilation on arrival. A bronchoalveolar lavage (BAL) culture was positive for Hemophilus influenzae and a respiratory viral panel was positive for Parainfluenza virus. The patient was initially started on Cefepime and Trimethoprim- Sulfamethoxazole and later changed to Ceftriaxone based on culture results. As the patient’s condition did not improve after 48 h, oral ribavirin was added to treat PIV. The patient subsequently improved and was extubated after 72 h. CONCLUSIONS: Oral ribavirin can have a beneficial effect in AIDS patients who have PIV-associated pneumonia. Further investigation of the benefit of oral ribavirin in similar cases is warranted.
format Online
Article
Text
id pubmed-7377600
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-73776002020-08-05 Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS Nagarakanti, Sandhya Bishburg, Eliahu Am J Case Rep Articles Patient: Male, 64-year-old Final Diagnosis: Hemophilus influenzae and parainfluenza virus pneumonia in a patient with AIDS Symptoms: Shortness of breath Medication:— Clinical Procedure: Bronchoalveolar lavage Specialty: Infectious Diseases OBJECTIVE: Rare disease BACKGROUND: Parainfluenza viruses (PIV) are known to cause mild respiratory tract infections in immunocompetent patients but can cause severe infections in immune-compromised patients such as transplant recipients and children with HIV. PIV infection in HIV-infected adults has rarely been reported. We report a case of PIV pneumonia in an adult with AIDS who was successfully treated with oral ribavirin. CASE REPORT: A 64-year-old man with history of acquired immune deficiency syndrome (AIDS) was admitted to the hospital with shortness of breath that began 3 days before. He was in respiratory distress and required mechanical ventilation on arrival. A bronchoalveolar lavage (BAL) culture was positive for Hemophilus influenzae and a respiratory viral panel was positive for Parainfluenza virus. The patient was initially started on Cefepime and Trimethoprim- Sulfamethoxazole and later changed to Ceftriaxone based on culture results. As the patient’s condition did not improve after 48 h, oral ribavirin was added to treat PIV. The patient subsequently improved and was extubated after 72 h. CONCLUSIONS: Oral ribavirin can have a beneficial effect in AIDS patients who have PIV-associated pneumonia. Further investigation of the benefit of oral ribavirin in similar cases is warranted. International Scientific Literature, Inc. 2020-07-11 /pmc/articles/PMC7377600/ /pubmed/32651354 http://dx.doi.org/10.12659/AJCR.923132 Text en © Am J Case Rep, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Nagarakanti, Sandhya
Bishburg, Eliahu
Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS
title Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS
title_full Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS
title_fullStr Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS
title_full_unstemmed Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS
title_short Hemophilus influenzae and Parainfluenza Virus Pneumonia in a Patient with AIDS
title_sort hemophilus influenzae and parainfluenza virus pneumonia in a patient with aids
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377600/
https://www.ncbi.nlm.nih.gov/pubmed/32651354
http://dx.doi.org/10.12659/AJCR.923132
work_keys_str_mv AT nagarakantisandhya hemophilusinfluenzaeandparainfluenzaviruspneumoniainapatientwithaids
AT bishburgeliahu hemophilusinfluenzaeandparainfluenzaviruspneumoniainapatientwithaids